Genetic variants within the cancer susceptibility region 8q24 and ovarian cancer risk in Han Chinese women

Accumulating evidence suggests that genetic variants at chromosome 8q24 confer susceptibility to various types of cancer. This case-control study was designed to explore the relationship between genetic variants at 8q24 and ovarian cancer risk in Han Chinese women. Two variants (rs13281615 A > G and rs6983267 T > G) were genotyped in 377 ovarian cancer cases and 1034 cancer-free controls using TaqMan allelic discrimination assay. Logistic regression analysis revealed that the G allele of rs6983267 was significantly associated with increased risk of ovarian cancer (additive model: adjusted OR = 1.21, 95% CI = 1.01–1.43, P = 0.048; recessive model: adjusted OR = 1.51, 95% CI = 1.06–2.15, P = 0.023). However, no significant association was observed between rs13281615 and ovarian cancer. In stratified analysis, the risk effect of rs6983267 variant remained significant in premenopausal women (additive model: adjusted OR = 1.62, 95% CI = 1.18–2.23, P = 0.003). Summarily, this study suggested that 8q24 rs6983267 may contribute to the susceptibility of ovarian cancer in premenopausal Han Chinese women, supporting the pleiotropy of 8q24 in carcinogenesis.

[1]  Dahai Liu,et al.  A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk , 2016, Oncotarget.

[2]  Shihua Zhang,et al.  Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer , 2016, Oncotarget.

[3]  L. You,et al.  Long non-coding RNA PVT1 and cancer. , 2016, Biochemical and biophysical research communications.

[4]  R. Mi,et al.  Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. , 2015, International journal of clinical and experimental medicine.

[5]  S. Thibodeau,et al.  Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome. , 2015, Human molecular genetics.

[6]  H. Gabra,et al.  The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future. , 2014, British medical bulletin.

[7]  Yan Guo,et al.  Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk , 2014, Nature Genetics.

[8]  Jin-Tang Dong,et al.  Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[9]  N. Le,et al.  Occupational exposure and ovarian cancer risk , 2014, Cancer Causes & Control.

[10]  A. Lopes,et al.  A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study , 2014, Familial Cancer.

[11]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[12]  Hongbing Shen,et al.  Genetic Variants of IDE-KIF11-HHEX at 10q23.33 Associated with Type 2 Diabetes Risk: A Fine-Mapping Study in Chinese Population , 2012, PloS one.

[13]  I. Gram,et al.  Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition , 2011, British Journal of Cancer.

[14]  A. Whittemore,et al.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.

[15]  Michael D. Cole,et al.  Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells , 2010, Molecular and Cellular Biology.

[16]  Peter Kraft,et al.  Identification of a new prostate cancer susceptibility locus on chromosome 8q24 , 2009, Nature Genetics.

[17]  Esko Ukkonen,et al.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling , 2009, Nature Genetics.

[18]  V. Beral,et al.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2008, The Lancet.

[19]  Wen-Lin Kuo,et al.  Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer , 2007, Clinical Cancer Research.

[20]  Adam S. Kibel,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007 .

[21]  Steven Gallinger,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.

[22]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[23]  David Reich,et al.  A common genetic risk factor for colorectal and prostate cancer , 2007, Nature Genetics.

[24]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[25]  J. Hirschhorn,et al.  Genetic model testing and statistical power in population‐based association studies of quantitative traits , 2007, Genetic epidemiology.

[26]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[27]  S. Chow,et al.  Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer , 2004, International Journal of Gynecologic Cancer.

[28]  Hongxia Zhu,et al.  Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo , 2004, Breast Cancer Research.

[29]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[30]  S. R. Young,et al.  c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. , 1999, Experimental and molecular pathology.

[31]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.